Abstract
Fifty postpartum patients were randomly given either bromocriptine (2.5 mg by mouth b.i.d. x 30 doses) or breast binders for inhibiting lactation. The breast binder group had a high incidence of symptoms (breast pain, engorgement, secretion) for the first week postpartum; these symptoms rapidly decreased by the second week. Bromocriptine successfully suppressed the breast problems in virtually all of the patients who took the drug correctly. Because of the high rate of side effects and a significant incidence of 'rebound', the dosage of bromocriptine should probably be changed, and we recommend a revised dosage.
| Original language | English |
|---|---|
| Pages (from-to) | 719-721 |
| Number of pages | 3 |
| Journal | Southern Medical Journal |
| Volume | 77 |
| Issue number | 6 |
| State | Published - Jan 1 1984 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation. / Shapiro, A. G.; Thomas, L.
In: Southern Medical Journal, Vol. 77, No. 6, 01.01.1984, p. 719-721.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation
AU - Shapiro, A. G.
AU - Thomas, L.
PY - 1984/1/1
Y1 - 1984/1/1
N2 - Fifty postpartum patients were randomly given either bromocriptine (2.5 mg by mouth b.i.d. x 30 doses) or breast binders for inhibiting lactation. The breast binder group had a high incidence of symptoms (breast pain, engorgement, secretion) for the first week postpartum; these symptoms rapidly decreased by the second week. Bromocriptine successfully suppressed the breast problems in virtually all of the patients who took the drug correctly. Because of the high rate of side effects and a significant incidence of 'rebound', the dosage of bromocriptine should probably be changed, and we recommend a revised dosage.
AB - Fifty postpartum patients were randomly given either bromocriptine (2.5 mg by mouth b.i.d. x 30 doses) or breast binders for inhibiting lactation. The breast binder group had a high incidence of symptoms (breast pain, engorgement, secretion) for the first week postpartum; these symptoms rapidly decreased by the second week. Bromocriptine successfully suppressed the breast problems in virtually all of the patients who took the drug correctly. Because of the high rate of side effects and a significant incidence of 'rebound', the dosage of bromocriptine should probably be changed, and we recommend a revised dosage.
UR - http://www.scopus.com/inward/record.url?scp=0021274355&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021274355&partnerID=8YFLogxK
M3 - Article
C2 - 6729548
AN - SCOPUS:0021274355
VL - 77
SP - 719
EP - 721
JO - Southern Medical Journal
JF - Southern Medical Journal
SN - 0038-4348
IS - 6
ER -